About Profusa
Profusa is a company based in San Francisco (United States) founded in 2009. It operates as a HealthTech, and Product-as-a-Service. Profusa has raised $64.92 million across 19 funding rounds from investors including Nasdaq, NIH and HHS. Profusa offers products and services including Lumee Oxygen Platform and Glucose Biosensors. Profusa operates in a competitive market with competitors including Theranica, Mainstay Medical, Sooma Oy, SPR Therapeutics and ZetrOZ, among others.
- Headquarter San Francisco, United States
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Profusa, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$64.92 M (USD)
in 19 rounds
-
Latest Funding Round
$45 M (USD), Series C
Aug 14, 2018
-
Investors
Nasdaq
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Profusa
Profusa offers a comprehensive portfolio of products and services, including Lumee Oxygen Platform and Glucose Biosensors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Continuous tissue oxygen monitoring is enabled by this platform.
Glucose levels are monitored continuously with innovative biosensor technology.
Funding Insights of Profusa
Profusa has successfully raised a total of $64.92M across 19 strategic funding rounds. The most recent funding activity was a Series C round of $45 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 19
- Last Round Series C — $45.0M
-
First Round
First Round
(10 Mar 2011)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2018 | Amount | Series C - Profusa | Valuation | Tasly , Maxim Ventures | |
| Apr, 2017 | Amount | Grant - Profusa | Valuation |
investors |
|
| Sep, 2016 | Amount | Grant - Profusa | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Profusa
Profusa has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Nasdaq, NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Science focused early & growth stage VC firm investing in the US & China
|
Founded Year | Domain | Location | |
|
VC firm investing in geographies such as South Korea
|
Founded Year | Domain | Location | |
|
Early-stage US companies are invested in by Asset Management Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Profusa
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Profusa
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Profusa Comparisons
Competitors of Profusa
Profusa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theranica, Mainstay Medical, Sooma Oy, SPR Therapeutics and ZetrOZ, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic devices for pain management are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Provider of rehabilitation solutions for patients and doctors
|
|
| domain | founded_year | HQ Location |
Non-invasive neuromodulation therapies
|
|
| domain | founded_year | HQ Location |
Pioneers non-invasive devices for chronic pain relief through medical innovation.
|
|
| domain | founded_year | HQ Location |
Wearable bioelectronic devices for acoustic medicine treatments are developed.
|
|
| domain | founded_year | HQ Location |
Wearable therapeutic fabrics for pain management are offered by Nufabrx.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Profusa
Frequently Asked Questions about Profusa
When was Profusa founded?
Profusa was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Where is Profusa located?
Profusa is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Profusa a funded company?
Profusa is a funded company, having raised a total of $64.92M across 19 funding rounds to date. The company's 1st funding round was a Grant of $1.22M, raised on Mar 10, 2011.
What does Profusa do?
Profusa, Inc. is engaged in the development of innovative tissue-integrating biosensors designed for continuous monitoring of body chemistries. The companys flagship product, the Lumee Oxygen Platform, is utilized for real-time tissue oxygen monitoring and has received CE Mark approval in the European Union. Additionally, glucose biosensors are being pioneered to expand monitoring capabilities. Solutions are targeted at healthcare applications, particularly in critical limb ischemia and influenza detection, with potential for telehealth and remote patient monitoring. Research and partnerships, including DARPA-backed studies, are leveraged to enhance early disease detection and improve clinical management in the medical sector.
Who are the top competitors of Profusa?
Profusa's top competitors include Theranica, Mainstay Medical and Nufabrx.
What products or services does Profusa offer?
Profusa offers Lumee Oxygen Platform and Glucose Biosensors.
Who are Profusa's investors?
Profusa has 11 investors. Key investors include Nasdaq, NIH, HHS, Atinum Investment, and SBIR.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.